A glucose-depleting silica nanosystem for increasing reactive oxygen species and scavenging glutathione in cancer therapy
- 11 October 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 55 (89) , 13374-13377
Abstract
A novel silica nanosystem is fabricated to convert intracellular glucose to hydrogen peroxide for enhancing reactive oxygen species level and triggering p -quinomethane release to scavenge glutathione, achieving synergistic anticancer treatment.Keywords
Funding Information
- Agency for Science, Technology and Research (A1883c0005)
- National Research Foundation Singapore (NRF-NRFI2018-03)
This publication has 31 references indexed in Scilit:
- Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapyJournal of Controlled Release, 2018
- Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell deathNature Communications, 2015
- Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Nature Reviews Cancer, 2014
- Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug DeliveryChemistry of Materials, 2013
- Stimuli-responsive nanocarriers for drug deliveryNature Materials, 2013
- Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen SpeciesJournal of Medicinal Chemistry, 2012
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- Cancer cell killing via ROS: To increase or decrease, that is the questionCancer Biology & Therapy, 2008
- Reactive Oxygen Species: A Breath of Life or Death?Clinical Cancer Research, 2007
- The emerging role of reactive oxygen species in cancer therapyEuropean Journal of Cancer, 2004